Jacobs Bruce N.
Chief Financial Officer
CIK: 1821074
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 492 | $84.00 | $41,326.28 | View Details Filing |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 2,519 | $85.04 | $214,206.69 | View Details Filing |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 1,437 | $85.78 | $123,266.87 | View Details Filing |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 447 | $86.62 | $38,721.24 | View Details Filing |
| Mar 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | A | 17,650 | $0.00 | $0.00 | View Details Filing |
| Mar 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | A | 35,300 | $0.00 | $0.00 | View Details Filing |
| Mar 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 2,039 | $87.75 | $178,924.09 | View Details Filing |
| Mar 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 1,424 | $88.50 | $126,024.57 | View Details Filing |
| Mar 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | S | 4,113 | $89.66 | $368,760.89 | View Details Filing |